Abstract: Peptides having 12 to 30 amino acids with sequence homologous or corresponding to the sequence 1o-34 of RANTES having inhibitory activity against the human immunodeficiency virus (HIV) as well as anti-allergic and antiinflamatory activity.
Type:
Grant
Filed:
June 22, 2001
Date of Patent:
March 23, 2004
Assignees:
Fondazione Centro San Raffaele Del Monte Tabor, PRIMM S.r.l.